Premium
β‐Glucan ameliorates nonalcoholic steatohepatitis induced by methionine and choline‐deficient diet in mice
Author(s) -
Huang Tianyang,
Liu Yahui,
Li Huiming,
Zhang Ying,
Kong Dezhi,
Cui Guozhen
Publication year - 2020
Publication title -
journal of food biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.507
H-Index - 47
eISSN - 1745-4514
pISSN - 0145-8884
DOI - 10.1111/jfbc.13408
Subject(s) - glucan , nonalcoholic steatohepatitis , steatosis , chemistry , inflammation , endocrinology , biochemistry , medicine , pharmacology , nonalcoholic fatty liver disease , fatty liver , disease
Abstract Nonalcoholic steatohepatitis (NASH) is becoming a huge global health problem. Studies showed that β‐glucan displayed potent anti‐inflammatory and other multi‐beneficial pharmacological properties. Thus, the objective of this study was to investigate the effects of β‐glucan on NASH mice induced by the MCD diet. After 8 weeks of β‐glucan treatments, results showed that β‐glucan effectively decreased the serum ALT and AST levels compared with the MCD model. Besides, histopathological results demonstrated that β‐glucan significantly attenuated the fat accumulation, steatosis, and inflammation in the liver compared with that of the MCD group. Furthermore, the ER stress‐responsive proteins, including GRP78, p‐eiF‐2α, and p‐JNK, were markedly restrained by β‐glucan, while ERp57, p‐MAPK, and p‐Akt were significantly increased after β‐glucan treatment. Collectively, our results suggested that β‐glucan beneficially resisted NASH induced by the MCD diet. The ER stress response may be involved in the mechanisms of action of β‐glucan. Practical applications This study is the first to report the hepatoprotective activity of β‐glucan against MCD diet‐induced NASH in mice, mainly reflecting its ability to ameliorate hepatic lipid accumulation and inflammation, with the mechanism possibly involving mediating the ER stress signaling pathway. Our results suggest that the β‐glucan has good application prospects to be used as a raw material in functional foods for the clinical treatment of NASH.